Background: To investigate the association between exposure to environmental tobacco smoke (EVT) and the incidence of lung cancer (LC) in nonsmoking adults.
Introduction
Lung cancer (LC) is one of the most prevalent and deadliest human cancers. There were about 1.8 million new LC cases globally in 2012 that accounted for 13.0% of all cancer cases, and about 1.59 million deaths from LC that accounted for 19 .4% of all cancer deaths. [1] In China, LC ranked first in the incidence and mortality of all cancer. In the 1990s, the mortality of LC in China was 17.5/100,000, and the male mortality (24.3/100,000) was higher than female (10.7/100,000). [2] However, in 2009, the LC mortality increased to 45.57/100,000, with 61/100,000 of male mortality and 29.77/100,000 of female mortality. [3] Therefore, it's meaningful to emphasize the prevention of LC. In China, the morbidity number of LC accounts for 35.78% of all cancer cases worldwide; the mortality rate of LC accounts for 37.55% of all cancer deaths worldwide. [4] Smoking and secondhand smoke are the risk factors of LC, and there are 72.4% of nonsmokers exposed to second-hand smoke. [5] [6] [7] Many studies suggest that smoking is the most important risk factor of LC. [8, 9] However, the incidence of LC in nonsmoking population is still up, so it is essential to investigate the influence of ETS exposure on nonsmoking population. Because of the high incidence, poor prognosis, and serious infection to human health, it's important to explore the risk factor of LC in nonsmoking population and formulate the prevention and control strategies. Based on these considerations, the aim of this study was to perform a meta-analysis of all available literature to obtain updated evidence on the association between ETS exposure and LC in nonsmoking population.
Methods

Search strategy
The Cochrane, PubMed, Embase, CNKI (China National Knowledge Infrastructure), Wanfang, and Weipu (VIP) were searched for all the case-control studies regarding the association between the ETS exposure and LC risk of nonsmoker. Others related articles and reference materials were also searched. The latest research was performed on June 2017. Two investigators searched the literature independently; a third investigator was involved when a disagreement occurred. Ethics approval was waived because this study does not involve any human participants or animals.
Inclusion and exclusion criteria
A study was included if it was case-control study; the research objects in case group were nonsmoking population diagnosed with LC, the research objects in control group were cancer-free population that matched on age, gender, and ethnic background with case group; the data included OR and 95% CI; and only included English and Chinese articles.
A study was excluded if it was republished article, or the contents and results were same; data had obvious mistake or were uncomplete; and if it was case report, theoretical research, conference report, systematic review, meta-analysis, expert comment, or theoretical analysis.
All the studies were screened by 2 reviewers independently to determine whether they satisfied the criteria; discrepancies were resolved by third reviewer.
Data extraction and quality assessment
The analyses data were extracted from all the included studies and consisted of 2 parts: basic information and main outcomes. The first part was about the basic information: the author name, the sample size, the percentage of male, mean age. The second part was the clinical outcomes: the odds ratio of EVT exposure and LC incidence in different groups. All the above processes were done by 2 reviewers independently; disagreements between reviewers were resolved by discussion until a consensus was reached.
Statistical Analysis
All statistical analyses were performed in the STATA 10.0 (TX, USA). Chi-squared and I 2 tests were used to test the heterogeneity of clinical trial results and decide the analysis model (fixed-effect model or random-effect model). When the Chi-squared test P value was .05 and I 2 tests value was >50%, it was defined as acceptable heterogeneity and assessed by random-effects model. When the Chi-squared test P value was >.05 and I 2 tests value was 50%, it was defined as homogeneous data and assessed by fixed-effects model. The continuous variables are expressed as the mean ± standard deviation and analyzed by mean difference (MD). The categorical data are presented as percentages and analyzed by relative risk (RR) or odds ratio (OR). All the results were analyzed by OR and 95% CI.
Results
Characteristics of the included studies
A total of 1261 articles were searched by the indexes, and 1193 articles were excluded by screening the title or abstract, leaving 68 articles for further evaluation. After obtaining and thorough reviewing the complete manuscript, 48 articles did not meet the inclusion criteria: republished (6), cooking fumes or gene analysis (5) , no clinical outcomes (17) , nonqualified grouping (11), theoretical research (9) . At last 20 studies [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] were involved in the meta-analysis with 13,004 adults in the case group and 11,199 adults in the control group. The selection process is presented in Figure 1 . The main characteristics of the included studies are summarized in Table 1 . The basic information includes age and gender. Out of this, 11 studies investigated only females, 2 studies are unclear, and 7 studies investigated both males and females.
EVT exposure and risk of lung cancer incidence
Nine studies with 13,520 adults (case group, 8156; control group, 5364) reported the association between EVT exposure and risk of LC incidence. Based on the Chi-squared test P value (P = .003) and I 2 tests value (I 2 = 66.3%), we chose randomeffects model to analyze the association. The pooled results showed the risk of LC incidence was significantly higher (OR: 1.64, 95% CI: 1.34-2.01, Fig. 2 ) in exposure population than in nonexposure population.
In the subgroups analysis, we have investigated the association in subgroups of male and female. Seven studies with 12,526 adults (case group, 7966; control group, 4560) reported the association between EVT exposure and risk of LC incidence in male population. Based on the Chisquared test P value (P = .018) and I 2 tests value (I 2 = 60.6%), we chose random-effects model to analyze the association. The pooled results showed the risk of LC incidence was significantly higher (OR: 1.62, 95% CI: 1.16-2.28, Fig. 3 ) in exposure male population than in nonexposure male population.
Eleven studies with 15,718 adults (case group, 9199; control group, 6519) reported the association between EVT exposure and risk of LC incidence in female population. Based on the Chisquared test P value (P = .364) and I 2 tests value (I 2 = 8.4%), we chose fixed-effects model to analyze the association. The pooled results showed the risk of LC incidence was significantly higher (OR: 1.57, 95% CI: 1.43-1.72, Fig. 4 ) in exposure female population than in nonexposure female population.
EVT exposure at workplace and risk of lung cancer incidence
Three studies with 2024 adults (case group = 637, control group = 1387) reported the association between EVT exposure at workplace and risk of LC incidence. Based on the Chi-squared test P value (P = .134) and I 2 tests value (I 2 = 50.2%), we chose random-effects model to analyze the association. The pooled results showed the risk of LC incidence was significantly higher (OR: 1.78, 95% CI: 1.29-2.44, Fig. 5 ) in exposure population than in nonexposure population.
In the subgroups analysis, we have investigated the association in subgroups of male and female.
Three studies with 5219 adults (case group, 2419; control group, 2800) reported the association between EVT exposure at workplace and risk of LC incidence in male population. Based on the Chi-squared test P value (P = .014) and I 2 tests value (I 2 = 76.5%), we chose random-effects model to analyze the association. The pooled results showed the risk of LC incidence has no significant difference (OR: 1.51, 95% CI: 0.74-3.06, Fig. 6 ) between exposure male population and nonexposure male population.
Ten studies with 10,329 adults (case group, 4768; control group, 5561) reported the association between EVT exposure and risk of LC incidence in female population. Based on the Chi-squared test P value (P = .009) and I 2 tests value (I 2 = 58.8%), we chose random-effects model to analysis the association. The pooled results showed the risk of LC incidence has no significant difference (OR: 1.23, 95% CI: 0.99-1.53, Fig. 7 ) between exposure female population and nonexposure female population.
EVT exposure at home and risk of lung cancer incidence
Three studies with 2413 adults (case group, 769; control group, 1644) reported the association between EVT exposure at home and risk of LC incidence. Based on the Chi-squared test P value (P = .021) and I 2 tests value (I 2 = 74.0%), we chose randomeffects model to analyze the association. The pooled results showed the risk of LC incidence was significantly higher (OR: 1.53, 95% CI: 1.01-2.33, Fig. 8 ) in exposure population than in nonexposure population. In the subgroups analysis, we have investigated the association in subgroups of male and female.
Three studies with 5219 adults (case group, 2419; control group, 2800) reported the association between EVT exposure at home and risk of LC incidence in male population. Based on the Chi-squared test P value (P = .132) and I 2 tests value (I 2 = 50.7%), we chose random-effects model to analyze the association. The pooled results showed the risk of LC incidence has no significant difference (OR: 1.24, 95% CI: 0.68-2.26, Fig. 9 ) between exposure male population and nonexposure male population.
Six studies with 7304 adults (case group, 3365; control group, 3939) reported the association between EVT exposure at home and risk of LC incidence in female population. Based on the Chi- 
Discussion
Several similar meta-analyses explored the relationship between EVT exposure and LC. Taylor et al [30] found that passive smoking by a spouse increased the risk of LC in nonsmoking women (OR: 1.17, 95% CI: 1.17-1.37). Zou et al [31] suggested Figure 10 . Forest plot showing the association between EVT exposure at home and lung cancer incidence of female. that the relative risk of LC was associated with smoking in husband who had been exposed to ETS, and the relative risk of LC exposure to ETS was 1.16 (95% CI: 1.05-1.28). The relative risk for male nonsmokers was 1.48 (95% CI: 1.13-1.92). Jerrett et al [32] reported that the main risk factors for LC in nonsmoking women include lung disease, family history of cancer, and passive smoking. The LC relative risk for adult workplace ETS exposure was 1.47 (95% CI: 1.28-1.69). The LC relative risk of household ETS exposure in adulthood was 1.22 (95% CI: 1.09-1.36), and the LC relative risk of ETS exposure in all life stages was 1.52 (95% CI: 1.29-1.79). Zhao et al [33] found that there was statistical significance between passive smoking and LC (OR: 1.13, 95% CI: 1.05-1.21) and the relative risk of LC for ETS exposure in female was 1.50 (95% CI: 1.19-1.90), at workplace was 1.41(95% CI: 1.19-1.66). The comprehensive results of Fu et al [34] showed that ETS exposure may increase the risk of LC with combined OR (95% CI) 1.52 (1.42-1.64); ETS exposure was found to be significantly associated with increased LC risk in nonsmoking men and women, with combined OR (95% CI) 1.58 (1.42-1.75) and 1.34 (1.08-1.65), respectively; Exposure of ETS from home or work environment may increase LC risk, with combined OR (95% CI) 1.48 (1.20-1.82) and 1.38 (1.13-1.69), respectively.
The tobacco smoke includes more than 7000 kinds of chemical substance. There have been several hundred poisonous chemical, 69 kinds of which are known as carcinogen. The carcinogen would damage DNA and lead to the incidence of LC; the basic principle of ETS exposure leading to LC is similar to smoking. ETS or passive smoking is defined as nonsmoker exposed in smoke that comes from the smokers exhale. The more smokers in environment.
However, there are some limitations which should be paid attention to in this analysis. The limitations are as follows: only case-control studies were included; differences in the inclusion criteria and exclusion criteria for objects; LC patients with previous disease and treatments were unavailable; some of the included studies were old; all the included studies were from Chinese or English articles and this may be the source of bias; pooled date were used for analysis, and individual patients' data were unavailable, so it limited more comprehensive analysis.
